Literature DB >> 1192666

The etiology of steroid-induced avascular necrosis of bone. A laboratory and clinical study.

R L Cruess, D Ross, E Crawshaw.   

Abstract

An attempt was made to reproduce in the experimental animal the clinical condition of steroid induced avascular necrosis of bone. There was a decrease in the ability of subchondral osteocytes to metabolize H3 cytidine and an increased amount of cell death as indicated by the number of empty subchondral lacunae. Oil red O stain for intravascular fat demonstrated large accumulations of fat in subchondral vessels. Much of this fat was deformed and was surrounded by reticulin, leading to the conclusion that it was embolic. A study of human material showed intravascular fat and diminished number of osteocytes in patients on systemic steroids who had died without clinical evidence of avascular necrosis. In addition, intravascular fat was demonstrated in avascular femoral heads and humeral heads both from transplant patients and patients receiving steroids for other reasons. The most tenable explanation for this series of events involves steroid-induced fatty liver with subsequent showeres of fatty emboli, which lodge in the subchondral region owing to the microvascular anatomy. Cell death ensues, and the necrotic bone is partially removed by the normal resorptive mechanism, but steroids retard osteogenesis, lead to microfractures, and eventually sequester the involved area.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192666     DOI: 10.1097/00003086-197511000-00028

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  13 in total

1.  Late complications after total hip replacement in renal allograft recipients.

Authors:  J Romero; A Schreiber; U Binswanger
Journal:  Int Orthop       Date:  1994       Impact factor: 3.075

2.  STAT1-caspase 3 pathway in the apoptotic process associated with steroid-induced necrosis of the femoral head.

Authors:  Xinxian Xu; Hong Wen; Yuezheng Hu; Huachen Yu; Yu Zhang; Chengwang Chen; Xiaoyun Pan
Journal:  J Mol Histol       Date:  2014-02-20       Impact factor: 2.611

3.  Surgical management of complications of steroid therapy.

Authors:  A G Diethelm
Journal:  Ann Surg       Date:  1977-03       Impact factor: 12.969

4.  Increased blood cortisol in alcoholic patients with aseptic necrosis of the femoral head.

Authors:  H Rico; F Gomez-Castresana; J A Cabranes; I Almoguera; L Lopez Duran; J A Matute
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333

5.  Progranulin Protects Against Osteonecrosis of the Femoral Head by Activating ERK1/2 Pathway.

Authors:  Yingguang Han; Meng Si; Yunpeng Zhao; Yi Liu; Kaiyuan Cheng; Yuedong Zhang; Jialin Jia; Jingkun Li; Lin Nie
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 6.  [Aseptic necrosis of the femoral head in young adults].

Authors:  H M Vasey
Journal:  Int Orthop       Date:  1984       Impact factor: 3.075

7.  Histopathology of femoral head osteonecrosis in rheumatoid arthritis: the relationship between steroid therapy and lipid degeneration in the osteocyte.

Authors:  Y Watanabe; K Kawai; K Hirohata
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  The immune reaction to heterologous serum causes osteonecrosis in rabbits.

Authors:  M Matsui; K Ohzono; N Nakamura; N Sugano; K Masuhara; K Nakata; K Takaoka; K Ono; T Ochi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study.

Authors:  Miranda L Davies-Tuck; Fahad Hanna; Susan R Davis; Robin J Bell; Sonia L Davison; Anita E Wluka; Jenny Adams; Flavia M Cicuttini
Journal:  Arthritis Res Ther       Date:  2009-12-04       Impact factor: 5.156

10.  Significant association of SREBP-2 genetic polymorphisms with avascular necrosis in the Korean population.

Authors:  Tae-Ho Kim; Jeong-In Baek; Jung Min Hong; Su-Jin Choi; Hye-Jin Lee; Hyun-Ju Cho; Eui Kyun Park; Un-Kyung Kim; Shin-Yoon Kim
Journal:  BMC Med Genet       Date:  2008-10-27       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.